Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY: DGX )

152.87 -0.55 (-0.36%)
Streaming Delayed Price Updated: 11:58 AM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Understanding Quest Diagnostics's Ex-Dividend Date
On May 20, 2021, Quest Diagnostics (NYSE:DGX) announced shar... 
Via Benzinga
Lots Of Bearish Sentiment Toward Quest Diagnostics, And That Could Help The Stock Move Higher
Quest Diagnostics has been trending higher for the last 16 months and a trend channel has formed that helps define the different cycles within the overall trend. Analysts and short sellers are... 
Via Talk Markets
Quest Diagnostics Releases Annual Corporate Responsibility Report
SOURCE: 3BL Alerts 
Via 3BL Media
Exposures COVID-19
Biocept Stock Moves Higher On Collaboration With Quest Diagnostics For Liquid Biopsy Testing For Lung Cancer Patients
Biocept Inc (NASDAQ: BIOC) has collaborated with Quest Diagnostics Inc (NYSE: DGX) to provide laboratory testing services to Quest patients for its Target... 
Via Benzinga
Biocept to Collaborate with Quest Diagnostics to Provide Advanced NGS-Based Liquid Biopsy Testing for Patients with Lung Cancer
From Biocept, Inc.
Via Business Wire
Quest Diagnostics Keeps Slumping, Here’s The Trade
Quest Diagnostics Inc stock has excellent support around the $118.00 level. This support area is where the stock broke out to the upside back in March 2021. 
Via Talk Markets
Stocks That Hit 52-Week Highs On Monday
This morning 792 companies reached new 52-week highs. Points of Interest: JPMorgan Chase (NYSE: JPM) was the largest company by market cap to set a new 52-week high. The... 
Via Benzinga
2 Incredibly Cheap Healthcare Stocks
These companies dominate a vital medical industry niche, and their valuations are near their all-time lows. 
Via The Motley Fool
The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,... 
Via Benzinga
Exposures COVID-19 Product Safety
5 Value Stocks To Watch In The Healthcare Sector
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
IBD Rating Upgrades: Laboratory Corporation Of America Key Stock Rating Climbs Amid 279% Profit Growth On 47% Sales Surge
The 73 RS Rating means Labcorp has outperformed 73% of all stocks over the past year. It's good but not great. However, other key ratings are outstanding. 
Via Investor's Business Daily
Exposures COVID-19
Agiliti Stock Clears Key Benchmark, Hitting 80-Plus RS Rating
Agiliti stock had its Relative Strength Rating upgraded from 80 to 85 Tuesday. An RS Rating over the key 80 benchmark makes Agiliti a stock to watch. 
Via Investor's Business Daily
Social & Health Research Center and Quest Diagnostics Team Up to Address Childhood Hunger and Obesity Exacerbated by COVID-19 in Underserved Communities
SOURCE: Quest Diagnostics 
Via 3BL Media
Topics Economy
Exposures COVID-19 Economy
10 Biggest Price Target Changes For Tuesday
Bernstein lifted the price target on The Boeing Company (NYSE: BA) from $196 to $229. Boeing shares rose 0.5% to $236.39 in pre-market trading. Goldman Sachs cut The Kroger Co... 
Via Benzinga
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... 
Via Benzinga
Exposures COVID-19 Product Safety
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... 
Via Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2021
Upgrades For Genuine Parts Co (NYSE:GPC), Goldman Sachs upgraded the previous rating of Sell to Neutral. In the first quarter, Genuine Parts showed an EPS of $1.50,... 
Via Benzinga
Quest Diagnostics Inc (DGX) Q1 2021 Earnings Call Transcript
DGX earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Recap: Quest Diagnostics Q1 Earnings
Shares of Quest Diagnostics (NYSE:DGX) rose 0.0% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 300.00% year... 
Via Benzinga
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,... 
Via Benzinga
The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs
The FDA and CDC announced their recommendation to pause the use of Johnson & Johnson's JNJ COVID-19 vaccine following incidences of severe clots. J&J's pain turned into gains for other COVID-19 vaccine... 
Via Talk Markets
Exposures COVID-19 Product Safety
Earnings Scheduled For April 22, 2021
Companies Reporting Before The Bell • Republic First Bancorp (NASDAQ:FRBK) is estimated to report quarterly earnings at $0.05 per share on revenue of $36.85 million.... 
Via Benzinga
The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs
Biotech stocks reversed course in the week ended April 16, with the sector rebounding along with the broader market. The week's news flow was fairly light. The American... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.